skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Early Low-Titer Neutralizing Antibodies Impede HIV-1 Replication and Select for Virus Escape

Journal Article · · PLoS Pathogens
 [1];  [2];  [1];  [3];  [4];  [2];  [2];  [2];  [2];  [2];  [5];  [5];  [1];  [1];  [3];  [6];  [7];  [5];  [5];  [4] more »;  [4];  [2];  [2];  [2];  [1];  [4];  [1] « less
  1. Univ. of Pennsylvania, Philadelphia, PA (United States). Perelman School of Medicine
  2. Duke Univ., Durham, NC (United States). School of Medicine
  3. Univ. of Alabama, Birmingham, AL (United States)
  4. National Institutes of Health (NIH), Bethesda, MD (United States). National Inst. of Allergy and Infectious Disease. Vaccine Research Center
  5. Los Alamos National Lab. (LANL), Los Alamos, NM (United States)
  6. National Cancer Institute, Frederick, MD (United States). SAIC-Frederick Inc.
  7. Univ. of Tennessee, Knoxville, TN (United States)

Single genome sequencing of early HIV-1 genomes provides a sensitive, dynamic assessment of virus evolution and insight into the earliest anti-viral immune responses in vivo. By using this approach, together with deep sequencing, site-directed mutagenesis, antibody adsorptions and virus-entry assays, we found evidence in three subjects of neutralizing antibody (Nab) responses as early as 2 weeks post-seroconversion, with Nab titers as low as 1:20 to 1:50 (IC50) selecting for virus escape. In each of the subjects, Nabs targeted different regions of the HIV-1 envelope (Env) in a strain-specific, conformationally sensitive manner. In subject CH40, virus escape was first mediated by mutations in the V1 region of the Env, followed by V3. HIV-1 specific monoclonal antibodies from this subject mapped to an immunodominant region at the base of V3 and exhibited neutralizing patterns indistinguishable from polyclonal antibody responses, indicating V1–V3 interactions within the Env trimer. In subject CH77, escape mutations mapped to the V2 region of Env, several of which selected for alterations of glycosylation. And in subject CH58, escape mutations mapped to the Env outer domain. In all three subjects, initial Nab recognition was followed by sequential rounds of virus escape and Nab elicitation, with Nab escape variants exhibiting variable costs to replication fitness. Although delayed in comparison with autologous CD8 T-cell responses, our findings show that Nabs appear earlier in HIV-1 infection than previously recognized, target diverse sites on HIV-1 Env, and impede virus replication at surprisingly low titers. The unexpected in vivo sensitivity of early transmitted/ founder virus to Nabs raises the possibility that similarly low concentrations of vaccine-induced Nabs could impair virus acquisition in natural HIV-1 transmission, where the risk of infection is low and the number of viruses responsible for transmission and productive clinical infection is typically one.

Research Organization:
Los Alamos National Laboratory (LANL), Los Alamos, NM (United States)
Sponsoring Organization:
USDOE Office of Science (SC), Biological and Environmental Research (BER). Biological Systems Science Division
Grant/Contract Number:
AC52-06NA25396
OSTI ID:
1627903
Journal Information:
PLoS Pathogens, Vol. 8, Issue 5; ISSN 1553-7374
Publisher:
Public Library of ScienceCopyright Statement
Country of Publication:
United States
Language:
English

References (74)

Vaccines: Correlates of Vaccine‐Induced Immunity journal August 2008
HIV vaccine design and the neutralizing antibody problem journal March 2004
Broadly Neutralizing Human Anti-HIV Antibody 2G12 Is Effective in Protection against Mucosal SHIV Challenge Even at Low Serum Neutralizing Titers journal May 2009
Limited Neutralizing Antibody Specificities Drive Neutralization Escape in Early HIV-1 Subtype C Infection journal September 2009
The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection journal June 2009
Molecular Architectures of Trimeric SIV and HIV-1 Envelope Glycoproteins on Intact Viruses: Strain-Dependent Variation in Quaternary Structure journal December 2010
Low-Dose Mucosal Simian Immunodeficiency Virus Infection Restricts Early Replication Kinetics and Transmitted Virus Variants in Rhesus Monkeys journal August 2010
Escape from Autologous Neutralizing Antibodies in Acute/Early Subtype C HIV-1 Infection Requires Multiple Pathways journal September 2009
Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9 journal November 2011
Immune and Genetic Correlates of Vaccine Protection Against Mucosal Infection by SIV in Monkeys journal May 2011
Generation of Transmitted/Founder HIV-1 Infectious Molecular Clones and Characterization of Their Replication Capacity in CD4 T Lymphocytes and Monocyte-Derived Macrophages journal December 2011
Broad neutralization coverage of HIV by multiple highly potent antibodies journal September 2011
Inflammatory Genital Infections Mitigate a Severe Genetic Bottleneck in Heterosexual Transmission of Subtype A and C HIV-1 journal January 2009
Analysis of Neutralization Specificities in Polyclonal Sera Derived from Human Immunodeficiency Virus Type 1-Infected Individuals journal November 2008
A Novel Antiviral Intervention Results in More Accurate Assessment of Human Immunodeficiency Virus Type 1 Replication Dynamics and T-Cell Decay In Vivo journal April 2003
The Role of Antibodies in HIV Vaccines journal March 2010
Effective, low-titer antibody protection against low-dose repeated mucosal SHIV challenge in macaques journal June 2009
Rapid Escape from Preserved Cross-Reactive Neutralizing Humoral Immunity without Loss of Viral Fitness in HIV-1-Infected Progressors and Long-Term Nonprogressors journal January 2010
Estimation of the Initial Viral Growth Rate and Basic Reproductive Number during Acute HIV-1 Infection journal March 2010
Analysis of a Clonal Lineage of HIV-1 Envelope V2/V3 Conformational Epitope-Specific Broadly Neutralizing Antibodies and Their Inferred Unmutated Common Ancestors journal July 2011
Detection of minor drug-resistant populations by parallel allele-specific sequencing journal January 2007
Structure of a V3-Containing HIV-1 gp120 Core journal November 2005
Neutralizing Antibody Responses in Acute Human Immunodeficiency Virus Type 1 Subtype C Infection journal April 2007
Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody journal June 1998
Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection journal January 1995
Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection journal June 2009
HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation Time journal March 1996
Cell-to-cell spread of HIV permits ongoing replication despite antiretroviral therapy journal August 2011
The B Cell Response Is Redundant and Highly Focused on V1V2 during Early Subtype C Infection in a Zambian Seroconverter journal October 2010
Neutralizing antibodies generated during natural HIV-1 infection: good news for an HIV-1 vaccine? journal June 2009
Wide Variation in the Multiplicity of HIV-1 Infection among Injection Drug Users journal April 2010
Tiered Categorization of a Diverse Panel of HIV-1 Env Pseudoviruses for Assessment of Neutralizing Antibodies journal November 2009
Genetic and Neutralization Properties of Subtype C Human Immunodeficiency Virus Type 1 Molecular env Clones from Acute and Early Heterosexually Acquired Infections in Southern Africa journal September 2006
Structure of HIV-1 gp120 with gp41-interactive region reveals layered envelope architecture and basis of conformational mobility journal December 2009
Determinants of Human Immunodeficiency Virus Type 1 Escape from the Primary CD8+ Cytotoxic T Lymphocyte Response journal November 2004
Broad and Potent Neutralizing Antibody Responses Elicited in Natural HIV-2 Infection journal October 2011
Low-dose rectal inoculation of rhesus macaques by SIVsmE660 or SIVmac251 recapitulates human mucosal infection by HIV-1 journal May 2009
Structural Comparison of HIV-1 Envelope Spikes with and without the V1/V2 Loop journal December 2010
Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection journal May 2008
Fitness Costs and Diversity of the Cytotoxic T Lymphocyte (CTL) Response Determine the Rate of CTL Escape during Acute and Chronic Phases of HIV Infection journal August 2011
Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand journal December 2009
Structural Basis for Broad and Potent Neutralization of HIV-1 by Antibody VRC01 journal July 2010
Evidence for Potent Autologous Neutralizing Antibody Titers and Compact Envelopes in Early Infection with Subtype C Human Immunodeficiency Virus Type 1 journal June 2006
HIV Evolution in Early Infection: Selection Pressures, Patterns of Insertion and Deletion, and the Impact of APOBEC journal May 2009
High Multiplicity Infection by HIV-1 in Men Who Have Sex with Men journal May 2010
A Limited Number of Simian Immunodeficiency Virus (SIV) env Variants Are Transmitted to Rhesus Macaques Vaginally Inoculated with SIVmac251 journal May 2010
Modelling viral and immune system dynamics journal January 2002
Neutralizing antibody responses drive the evolution of human immunodeficiency virus type 1 envelope during recent HIV infection journal December 2005
Potent Intratype Neutralizing Activity Distinguishes Human Immunodeficiency Virus Type 2 (HIV-2) from HIV-1 journal November 2011
Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection journal January 2003
Rapid evolution of the neutralizing antibody response to HIV type 1 infection journal March 2003
Potent Autologous and Heterologous Neutralizing Antibody Responses Occur in HIV-2 Infection across a Broad Range of Infection Outcomes journal November 2011
Antiviral pressure exerted by HIV-l-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus journal February 1997
Molecular architecture of native HIV-1 gp120 trimers journal July 2008
Protection of Macaques against Pathogenic Simian/Human Immunodeficiency Virus 89.6PD by Passive Transfer of Neutralizing Antibodies journal January 1999
Cell-to-Cell Transfer of HIV-1 via Virological Synapses Leads to Endosomal Virion Maturation that Activates Viral Membrane Fusion journal December 2011
The C3-V4 Region Is a Major Target of Autologous Neutralizing Antibodies in Human Immunodeficiency Virus Type 1 Subtype C Infection journal December 2007
Transmission of Single HIV-1 Genomes and Dynamics of Early Immune Escape Revealed by Ultra-Deep Sequencing journal August 2010
Antibody neutralization and escape by HIV-1 journal March 2003
Estimating time since infection in early homogeneous HIV-1 samples using a poisson model journal October 2010
Autologous Neutralizing Antibodies to the Transmitted/Founder Viruses Emerge Late after Simian Immunodeficiency Virus SIVmac251 Infection of Rhesus Monkeys journal March 2010
Modeling sequence evolution in acute HIV-1 infection journal November 2009
Immunotypes of a Quaternary Site of HIV-1 Vulnerability and Their Recognition by Antibodies journal February 2011
Specificity of the autologous neutralizing antibody response journal January 2009
Roles of HIV-1 Env Variable Regions in Viral Neutralization and Vaccine Development journal November 2007
Specific Antibody Responses to Vaccination with Bivalent CM235/SF2 gp120: Detection of Homologous and Heterologous Neutralizing Antibody to Subtype E (CRF01.AE) HIV Type 1 journal September 2003
Viral dynamics in human immunodeficiency virus type 1 infection journal January 1995
Viral Dynamics of Acute HIV-1 Infection journal September 1999
High titer HIV-1 V3-specific antibodies with broad reactivity but low neutralizing potency in acute infection and following vaccination journal May 2009
Role of V1V2 and Other Human Immunodeficiency Virus Type 1 Envelope Domains in Resistance to Autologous Neutralization during Clade C Infection journal November 2006
Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection
  • F., Salazar-Gonzalez, Jesus; P., Busch, Michael; S., Perelson, Alan
  • The University of North Carolina at Chapel Hill University Libraries https://doi.org/10.17615/f6s9-vz03
text January 2008
Effective, low-titer antibody protection against low-dose repeated mucosal SHIV challenge in macaques text January 2009
Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection text January 2009
For HIV, It's Never Too Late to Grow Up journal December 2011

Cited By (15)

Estimating the mutational fitness effects distribution during early HIV infection journal July 2018
Achieving Potent Autologous Neutralizing Antibody Responses against Tier 2 HIV-1 Viruses by Strategic Selection of Envelope Immunogens journal March 2016
B-cell restriction – an alternative piece to the puzzle journal April 2019
Uninfected Bystander Cells Impact the Measurement of HIV-Specific Antibody-Dependent Cellular Cytotoxicity Responses journal March 2018
A multiple-alignment based primer design algorithm for genetically highly variable DNA targets journal January 2013
HIV evolution and diversity in ART-treated patients journal January 2018
In vivo mutation rates and the landscape of fitness costs of HIV-1 text January 2017
Transmitted Virus Fitness and Host T Cell Responses Collectively Define Divergent Infection Outcomes in Two HIV-1 Recipients journal January 2015
Novel HIV vaccine strategies: overview and perspective journal July 2013
Increasing the Clinical Potential and Applications of Anti-HIV Antibodies journal November 2017
Is hiv Short-Sighted? Insights from a Multistrain Nested Model: Evolution of hiv Virulence journal June 2013
Relative resistance of HIV-1 founder viruses to control by interferon-alpha journal January 2013
Modeling the within-host dynamics of HIV infection journal September 2013
Spatiotemporal hierarchy in antibody recognition against transmitted HIV-1 envelope glycoprotein during natural infection journal February 2016
Recombination Enhances HIV-1 Envelope Diversity by Facilitating the Survival of Latent Genomic Fragments in the Plasma Virus Population journal December 2015